BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8402661)

  • 21. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues.
    Wu HK; Squire JA; Song Q; Weksberg R
    Biochem Biophys Res Commun; 1997 Apr; 233(1):221-6. PubMed ID: 9144427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental regulation of genomic imprinting of the IGF2 gene in human liver.
    Davies SM
    Cancer Res; 1994 May; 54(10):2560-2. PubMed ID: 8168079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
    Xu YQ; Grundy P; Polychronakos C
    Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific-PCR.
    Yun K; Soejima H; Merrie AE; McCall JL; Reeve AE
    J Pathol; 1999 Apr; 187(5):518-22. PubMed ID: 10398115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers.
    Kondo M; Suzuki H; Ueda R; Osada H; Takagi K; Takahashi T; Takahashi T
    Oncogene; 1995 Mar; 10(6):1193-8. PubMed ID: 7700644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism.
    Ogawa O; Becroft DM; Morison IM; Eccles MR; Skeen JE; Mauger DC; Reeve AE
    Nat Genet; 1993 Dec; 5(4):408-12. PubMed ID: 8298652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
    Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
    Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour.
    Taniguchi T; Schofield AE; Scarlett JL; Morison IM; Sullivan MJ; Reeve AE
    Oncogene; 1995 Aug; 11(4):751-6. PubMed ID: 7651739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
    Yballe CM; Vu TH; Hoffman AR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata.
    Vu TH; Yballe C; Boonyanit S; Hoffman AR
    J Clin Endocrinol Metab; 1995 May; 80(5):1670-6. PubMed ID: 7745016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivation of the maternally imprinted IGF2 allele in TGFalpha induced hepatocellular carcinomas in mice.
    Harris TM; Rogler LE; Rogler CE
    Oncogene; 1998 Jan; 16(2):203-9. PubMed ID: 9464538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
    Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
    Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of imprinting of IGF2 in Ewing's sarcoma.
    Zhan S; Shapiro DN; Helman LJ
    Oncogene; 1995 Dec; 11(12):2503-7. PubMed ID: 8545106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma.
    Uchida K; Kondo M; Takeda S; Osada H; Takahashi T; Nakao A; Takahashi T
    Mol Carcinog; 1997 Apr; 18(4):193-8. PubMed ID: 9142213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
    Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
    Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type.
    Watanabe N; Haruta M; Soejima H; Fukushi D; Yokomori K; Nakadate H; Okita H; Hata JI; Fukuzawa M; Kaneko Y
    Genes Chromosomes Cancer; 2007 Oct; 46(10):929-35. PubMed ID: 17639583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Altered genomic imprinting in the IGF2 and H19 genes in human lung cancer].
    Kondo M; Takahashi T
    Nihon Rinsho; 1996 Feb; 54(2):492-6. PubMed ID: 8838103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity.
    Ohlsson R; Cui H; He L; Pfeifer S; Malmikumpu H; Jiang S; Feinberg AP; Hedborg F
    Cancer Res; 1999 Aug; 59(16):3889-92. PubMed ID: 10463576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytes.
    Vafiadis P; Bennett ST; Colle E; Grabs R; Goodyer CG; Polychronakos C
    J Autoimmun; 1996 Jun; 9(3):397-403. PubMed ID: 8816977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
    Watanabe N; Nakadate H; Haruta M; Sugawara W; Sasaki F; Tsunematsu Y; Kikuta A; Fukuzawa M; Okita H; Hata J; Soejima H; Kaneko Y
    Genes Chromosomes Cancer; 2006 Jun; 45(6):592-601. PubMed ID: 16518847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.